Data from this sample of US type 2 diabetes revealed some interesting differences between insulin-naïve and insulin-treated patients, suggesting a trend towards a less negative appraisal of insulin therapy in those who actually are on insulin treatment. The gene discussed is INS; the disease is type 2 diabetes mellitus.